Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Simvastatin and Membrane Bilayer Modulation
2026-08-17
The 2021 study by Teo and Tieleman used all-atom molecular dynamics simulations to distinguish how the lactone and active dihydroxyheptanoate forms of Simvastatin partition into and reshape phospholipid bilayers. Its results connect simvastatin chemical state and membrane composition with changes in localization, hydrogen bonding, membrane order, and fluidity, offering a mechanistic framework for interpreting both therapeutic and pleiotropic effects.
-
Bromodomain Inhibitor (+)-JQ1: Applied Workflows
2026-08-17
Build reproducible BET-signaling experiments with (+)-JQ1 across transcriptional regulation, apoptosis, ferroptosis sensitivity, inflammation, and BRDT-focused reproductive biology. This guide connects practical dosing and assay design to a 2025 BRD4–TXNIP–UFMylation mechanism while emphasizing solvent control, timing, and orthogonal validation.
-
Lipo3K Transfection Reagent for Ferroptosis
2026-08-16
Lipo3K Transfection Reagent enables a mechanism-focused workflow for studying OTUD3, SLC7A11, and sunitinib resistance in clear cell renal cell carcinoma. This guide connects low-toxicity nucleic acid delivery with rigorous gene expression studies and RNA interference research, while separating product capabilities from literature-derived findings.
-
Crizotinib in Patient-Derived Tumor Assembloids
2026-08-15
A mechanistic and translational framework for using Crizotinib hydrochloride to interrogate ALK, MET, and ROS1 signaling in patient-derived gastric cancer assembloids, with practical guidance for separating tumor-cell effects from stromal protection and resistance.
-
Recombinant Human EGF: Mechanism and Use
2026-08-14
Epidermal Growth Factor and recombinant human EGF support controlled studies of EGFR signaling, cell proliferation, differentiation, and mucosal biology. The P1008 preparation combines a documented recombinant format with a BALB/c 3T3 bioassay benchmark, but its ED50 is assay-specific and does not establish therapeutic efficacy.
-
(S)-(+)-Dimethindene maleate Guide
2026-08-14
(S)-(+)-Dimethindene maleate provides a defined research reagent for probing M2 muscarinic acetylcholine receptor signaling while accounting for concurrent histamine H1 antagonism. This guide explains preparation, controls, and quality checks for autonomic regulation, cardiovascular physiology, and respiratory system function assays; it should not be used to infer clinical effects, potency, or long-term solution stability without assay-specific validation.
-
p21 mRNA–LNP Therapy for Bladder Cancer
2026-08-13
A 2026 FASEB Journal study developed intravesical lipid nanoparticles carrying chemically modified p21 mRNA as a localized tumor suppressor replacement strategy for bladder cancer. The approach restored nuclear p21, inhibited tumor-cell growth, and reduced orthotopic tumor burden while limiting systemic protein expression, supporting further investigation of localized mRNA delivery.
-
(S)-(+)-Dimethindene maleate: Lab Guide
2026-08-13
(S)-(+)-Dimethindene maleate provides a defined research reagent for studying M2 muscarinic receptor antagonism while accounting for its stated activity at histamine H1 receptors. This guide covers identity, solution handling, controls, and QC for pharmacological workflows; it is for scientific research only, not diagnostic or medical use, and no directly matched paper evidence is supplied for SKU B6734.
-
Cucurbitacin I: STAT3 Workflow for Cancer Research
2026-08-12
Build a causal STAT3 study around Cucurbitacin I (JSI-124) by combining phospho-STAT3, DNA-binding, phenotype, and selectivity readouts. This practical framework also adapts the compartment-aware logic of human SAN-plexus assembloids without making unsupported cardiac efficacy claims.
-
DHEA Workflows for PCOS and Neuroprotection
2026-08-12
Dehydroepiandrosterone (DHEA) can serve as both a controlled hyperandrogenic challenge and a mechanistic probe for neural survival, depending on the experimental context. This guide connects ovarian steroidogenesis, granulosa cell proliferation, apoptosis inhibition, and hippocampal neuron protection to practical dosing, controls, and troubleshooting decisions.
-
Dasatinib: Workflows for Src and Bcr-Abl Research
2026-08-11
Dasatinib (BMS-354825) provides a practical way to interrogate Src-, Bcr-Abl-, and FAK-linked signaling across cancer models. This guide translates its biochemical potency into controlled cell-based workflows, phosphoprotein assays, metastatic research, and troubleshooting strategies without confusing kinase inhibition with direct SNAI1 targeting.
-
JSH-23: A Precision Lens on NF-κB Translation
2026-08-11
JSH-23 offers translational researchers a mechanism-focused way to separate NF-κB p65 transcriptional activity from upstream pathway activation, inflammatory output, and inflammasome execution. This article connects macrophage, viral-infection, and kidney-injury evidence while defining the opportunities and limits of using this NF-κB inhibitor as a research tool.
-
Glucocorticoids, Kv2.1, and CaV1.2 in Neurons
2026-08-10
A 2024 Journal of Neuroscience study identifies a rapid nongenomic mechanism by which glucocorticoids suppress CaV1.2-dependent calcium signals in hippocampal neurons. The work links reduced PKA activity to endocytosis of Kv2.1 channel clusters, revealing how membrane organization can regulate calcium entry without requiring transcriptional changes.
-
CAY10499 for EV-Driven Lipid Metabolism Assays
2026-08-09
CAY10499, an inhibitor of human hormone sensitive lipase, provides a practical way to separate lipid hydrolysis from ACLY-driven lipid synthesis in macrophage and tumor microenvironment studies. This article translates recent extracellular-vesicle findings into assay design, controls, and disease-relevant applications.
-
Alcian Blue & Nuclear Fast Red Staining Kit Guide
2026-08-08
Build clearer acid-mucin and cartilage-matrix readouts with a practical dual-staining workflow for tissue sections, biopsy material, and mesenchymal stem cell assays. This guide connects stain chemistry with sample handling, assay controls, and troubleshooting so blue extracellular matrix and red nuclear morphology remain interpretable.